Immune Imprinting and Antibody Profiles to SARS-CoV-2 in Urban and Rural Ghana

Infections with SARS-CoV-2 and the development of immunity to the virus and its antigenic variants have been unevenly documented globally, with African populations particularly understudied. As SARS-CoV-2 transitions towards being an endemic pathogen, more nuanced understanding of immune protection in diverse populations is required. In 2023, we conducted a cross-sectional study of 1,000 Ghanaian residents to assess SARS-CoV-2 prevalence and antibody correlates of immunity against SARS-CoV-2 variants. We found an active SARS-CoV-2 infection rate of 1.3% and a 57% vaccination rate. We observed anti-SARS-CoV-2 Spike plasma antibody sero-positivity of 98.7%, with urban compared to rural residents having higher anti-SARS-CoV-2 plasma and saliva antibody concentrations. Vaccinated and urban individuals exhibited significantly greater Spike-pseudotyped virus neutralization than nonvaccinated and rural individuals. Notably, plasma antibodies preferentially bound Wuhan-Hu-1 SARS-CoV-2 over Omicron Spike variants. Our findings indicate significant prior and ongoing SARS-CoV-2 transmission as well as immunological imprinting by Wuhan-Hu-1-like SARS-CoV-2 in Ghana.

Antigen and antibody data in this study were generated using electrochemiluminescence (ECL)-based Meso Scale Discovery (MSD) assays. This Mendeley dataset includes MSD Arbitrary Units derived from ECL data. Additionally, the dataset contains Spike-pseudotyped virus neutralization percentages and deidentified demographic information for the study participants, including town of residence, sex, and COVID-19 vaccination status. Age information has been excluded to maintain participant privacy.